Edgewise Therapeutics, Inc. ( EWTX) - Key Metrics
EWTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.53 | -$0.40 | -$0.40 |
| 2026Q1 | $0 | -$0.46 | -$0.40 | -$0.40 |
| 2025Q4 | $0 | -$0.49 | -$0.37 | -$0.37 |
| 2025Q3 | $0 | -$0.39 | -$0.33 | -$0.33 |
| 2025Q2 | $0 | -$0.34 | -$0.31 | -$0.31 |
EWTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -19.17 |
| 2026Q1 | 0% | -17.12 |
| 2025Q4 | 0% | -13.20 |
| 2025Q3 | 0% | -10.40 |
| 2025Q2 | 0% | -9.64 |
EWTX
Price: $44.17
52 week price:
Earnings Per Share: -1.84 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 74985
Market Capitalization: 4.8 billion